Related Experiment Video
Updated: Jul 14, 2026

Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons
Published on: November 6, 2017
Mechanism of cell death caused by complex I defects in a rat dopaminergic cell line
Mathieu Marella1, Byoung Boo Seo, Akemi Matsuno-Yagi
1Division of Biochemistry, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California 92037, USA.
Abstract:
Defects in the proton-translocating NADH-quinone oxidoreductase (complex I) of mammalian mitochondria are linked to neurodegenerative disorders. The mechanism leading to cell death elicited by complex I deficiency remains elusive. We have shown that expression of a rotenone-insensitive yeast NADH-quinone oxidoreductase (Ndi1) can rescue mammalian cells from complex I dysfunction. By using the Ndi1 enzyme, we have investigated the key events in the process of cell death using a rat dopaminergic cell line, PC12. We found that complex I inhibition provokes the following events: 1) activation of specific kinase pathways; 2) release of mitochondrial proapoptotic factors, apoptosis inducing factor, and endonuclease G. AS601245, a kinase inhibitor, exhibited significant protection against these apoptotic events. The traditional caspase pathway does not seems to be involved because caspase 3 activation was not observed. Our data suggest that overproduction of reactive oxygen species (ROS) caused by complex I inhibition is responsible for triggering the kinase activation, for the release of the proapoptotic factors, and then for cell death. Nearly perfect prevention of apoptotic cell death by Ndi1 agrees with our earlier observation that the presence of Ndi1 diminishes rotenone-induced ROS generation from complex I. In fact, this study demonstrated that Ndi1 keeps the redox potential high even in the presence of rotenone. Under these conditions, ROS formation by complex I is known to be minimal. Possible use of our cellular model is discussed with regard to development of therapeutic strategies for neurodegenerative diseases caused by complex I defects.
Insights
Mitochondrial complex I defects cause neurodegeneration. Yeast Ndi1 enzyme prevents cell death by reducing reactive oxygen species (ROS) and kinase activation, offering a potential therapeutic strategy for these disorders.
Area of Science:
- Mitochondrial biochemistry
- Neurobiology
- Cell death pathways
Background:
- Defects in mitochondrial NADH-quinone oxidoreductase (complex I) are implicated in neurodegenerative diseases.
- The precise mechanisms driving cell death due to complex I deficiency are not fully understood.
Purpose of the Study:
- To investigate the key events leading to cell death in complex I deficiency using a rat dopaminergic cell line (PC12).
- To explore the protective potential of the yeast NADH-quinone oxidoreductase (Ndi1) enzyme against complex I dysfunction.
Main Methods:
- Utilized the rotenone-insensitive yeast Ndi1 enzyme to rescue mammalian cells from complex I dysfunction.
- Investigated cell death pathways, including kinase activation and mitochondrial proapoptotic factor release.
- Assessed the role of reactive oxygen species (ROS) and caspase activation.
Main Results:
- Complex I inhibition triggered kinase pathway activation and release of mitochondrial proapoptotic factors (apoptosis-inducing factor, endonuclease G).
- A kinase inhibitor (AS601245) provided significant protection, while caspase 3 activation was not observed.
- The yeast Ndi1 enzyme nearly completely prevented apoptotic cell death by maintaining high redox potential and reducing ROS generation.
Conclusions:
- Reactive oxygen species (ROS) overproduction, driven by complex I inhibition, is a key mediator of kinase activation, proapoptotic factor release, and subsequent cell death.
- The caspase-independent cell death pathway is involved.
- The Ndi1 enzyme demonstrates significant therapeutic potential for neurodegenerative diseases linked to complex I defects by mitigating ROS production.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cellular Injury IV: Necrosis
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Cellular Injury I: Introduction
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...
